These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 33401172)

  • 21. Universal screening for SARS-CoV-2 infection: a rapid review.
    Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modeling fomite-mediated SARS-CoV-2 exposure through personal protective equipment doffing in a hospital environment.
    King MF; Wilson AM; Weir MH; López-García M; Proctor J; Hiwar W; Khan A; Fletcher LA; Sleigh PA; Clifton I; Dancer SJ; Wilcox M; Reynolds KA; Noakes CJ
    Indoor Air; 2022 Jan; 32(1):e12938. PubMed ID: 34693567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative Microbial Risk Assessment for Airborne Transmission of SARS-CoV-2 via Breathing, Speaking, Singing, Coughing, and Sneezing.
    Schijven J; Vermeulen LC; Swart A; Meijer A; Duizer E; de Roda Husman AM
    Environ Health Perspect; 2021 Apr; 129(4):47002. PubMed ID: 33793301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitigation effect of face shield to reduce SARS-CoV-2 airborne transmission risk: Preliminary simulations based on computed tomography.
    Tretiakow D; Tesch K; Skorek A
    Environ Res; 2021 Jul; 198():111229. PubMed ID: 33932477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of social contacts on SARS-CoV-2 exposure among healthcare workers.
    Emecen AN; Keskin S; Boncukcu Eren E; Yildirim Ustuner B; Celik SG; Suner AF; Sezgin E; Siyve N; Basoglu Sensoy E; Tutal Altas E; Demiral Y
    Occup Med (Lond); 2022 Jan; 72(1):10-16. PubMed ID: 34633044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of medical face masks versus particulate respirators as a component of personal protective equipment for health care workers in the context of the COVID-19 pandemic.
    Conly J; Seto WH; Pittet D; Holmes A; Chu M; Hunter PR;
    Antimicrob Resist Infect Control; 2020 Aug; 9(1):126. PubMed ID: 32762735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-Coronavirus-2 cases in healthcare workers may not regularly originate from patient care: lessons from a university hospital on the underestimated risk of healthcare worker to healthcare worker transmission.
    Schneider S; Piening B; Nouri-Pasovsky PA; Krüger AC; Gastmeier P; Aghdassi SJS
    Antimicrob Resist Infect Control; 2020 Dec; 9(1):192. PubMed ID: 33287908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Saliva is a non-negligible factor in the spread of COVID-19.
    Li Y; Ren B; Peng X; Hu T; Li J; Gong T; Tang B; Xu X; Zhou X
    Mol Oral Microbiol; 2020 Aug; 35(4):141-145. PubMed ID: 32367576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of Face Mask or Respirator Use in Indoor Public Settings for Prevention of SARS-CoV-2 Infection - California, February-December 2021.
    Andrejko KL; Pry JM; Myers JF; Fukui N; DeGuzman JL; Openshaw J; Watt JP; Lewnard JA; Jain S;
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):212-216. PubMed ID: 35143470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific risk factors for SARS-CoV-2 transmission among health care workers in a university hospital.
    Çelebi G; Pişkin N; Çelik Bekleviç A; Altunay Y; Salcı Keleş A; Tüz MA; Altınsoy B; Hacıseyitoğlu D
    Am J Infect Control; 2020 Oct; 48(10):1225-1230. PubMed ID: 32771498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Synergistic Effect of Time of Exposure, Distance and No Use of Personal Protective Equipment in the Determination of SARS-CoV-2 Infection: Results of a Contact Tracing Follow-Up Study in Healthcare Workers.
    La Torre G; Marte M; Previte CM; Barone LC; Picchioni F; Chiappetta M; Faticoni A; Marotta D; Mazzalai E; Barletta VI; Kibi S; Cammalleri V; Dorelli B; Giffi M; Pocino RN; Massetti AP; Fimiani C; Turriziani O; Romano F; Antonelli G; Deales A; Mastroianni CM; Vasaturo F; On Behalf Of Collaborative Group Sapienza
    Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Effect of Personal Protective Equipment (PPE) and Disinfectants on Skin Health During Covid 19 Pandemia.
    Cebeci D; Karasel S; Rıfkı D; Yesildağlı H; Kalfaoglu M
    Med Arch; 2021 Oct; 75(5):361-365. PubMed ID: 35169358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 Exposure from Health Care Workers to Infants: Effects and Outcomes.
    Shaiba LA; Hadid A; Abdulghani SH; Hussain SA; Shah PS
    Am J Perinatol; 2023 May; 40(7):799-806. PubMed ID: 34450672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modeling the Stability of SARS-CoV-2 on Personal Protective Equipment (PPE).
    Haddow AD; Watt TR; Bloomfield HA; Fetterer DP; Harbourt DE
    Am J Trop Med Hyg; 2020 Dec; 104(2):549-551. PubMed ID: 33355071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of government pandemic policies on the vulnerability of healthcare workers to SARS-CoV-2 infection and mortality in Jakarta Province, Indonesia.
    Agustina R; Rianda D; Lamuri A; Ekawidyani KR; Siregar DAS; Sari DS; Wulan PM; Devana ND; Syam AF; Rahyussalim AJ; Handayani DO; Widyastuti W; Shankar AH; Salama N
    Ann Med; 2023; 55(2):2293306. PubMed ID: 38206905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real-world assessment, relevance, and problems in use of personal protective equipment in clinical dermatology practice in a COVID referral tertiary hospital.
    Arora P; Sardana K; Sinha S
    J Cosmet Dermatol; 2020 Dec; 19(12):3189-3198. PubMed ID: 32975000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of healthcare personnel exposures to patients with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) associated with personal protective equipment.
    Shah VP; Breeher LE; Hainy CM; Swift MD
    Infect Control Hosp Epidemiol; 2022 Jun; 43(6):770-774. PubMed ID: 33975656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of the COVID-19 Pandemic on Healthcare Workers' Risk of Infection and Outcomes in a Large, Integrated Health System.
    Misra-Hebert AD; Jehi L; Ji X; Nowacki AS; Gordon S; Terpeluk P; Chung MK; Mehra R; Dell KM; Pennell N; Hamilton A; Milinovich A; Kattan MW; Young JB
    J Gen Intern Med; 2020 Nov; 35(11):3293-3301. PubMed ID: 32875500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydroxychloroquine plus personal protective equipment versus standard personal protective equipment alone for the prevention of COVID-19 infections among frontline healthcare workers: the HydrOxychloroquine Prophylaxis Evaluation(HOPE) trial: A structured summary of a study protocol for a randomized controlled trial.
    Tirupakuzhi Vijayaraghavan BK; Jha V; Rajbhandari D; Myatra SN; John O; Ghosh A; Bassi A; Arfin S; Kunigari M; Joshi R; Donaldson L; Hammond N; Venkatesh B;
    Trials; 2020 Aug; 21(1):754. PubMed ID: 32867852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.